huge debt, declining revenue, overvalued assets..$350 MM in new cash, delayed Cinvin instalment, new BoD member. Smells like we are buying time to breath and prepare for new launches, acquire new products, ladies. There is strength with product diversity. Time for a new business model. Sell generics at fair prices, be sole provider of drugs at a fair price to treat rare diseases. Offer packaged pricing deals for a bag full of generics under Contract with 3rd party providers and govt health service. Higher market share with fairly priced products. Sounds pretty unstoppable. via more pills per prescription. Just loaded up again. I will have another million dollars with my current share count at 2015 prices, lol. Oh and btw shorty. No new share offerings or private or placements to your pirate equity. Nor did I see new options or warrants to anyone. Pleasant. All shares at this point have to be purchased on the open market. Fact.